AbbVie Inc (ABBV)
167.80
-1.74
(-1.03%)
USD |
NYSE |
Apr 24, 16:00
167.32
-0.48
(-0.29%)
Pre-Market: 06:28
AbbVie Cash and Short Term Investments (Quarterly): 12.82B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.82B |
| September 30, 2023 | 13.29B |
| June 30, 2023 | 8.766B |
| March 31, 2023 | 6.722B |
| December 31, 2022 | 9.229B |
| September 30, 2022 | 11.88B |
| June 30, 2022 | 9.961B |
| March 31, 2022 | 7.572B |
| December 31, 2021 | 9.83B |
| September 30, 2021 | 12.25B |
| June 30, 2021 | 8.60B |
| March 31, 2021 | 9.777B |
| December 31, 2020 | 8.479B |
| September 30, 2020 | 7.95B |
| June 30, 2020 | 6.04B |
| March 31, 2020 | 41.14B |
| December 31, 2019 | 39.92B |
| September 30, 2019 | 10.65B |
| June 30, 2019 | 5.416B |
| March 31, 2019 | 5.228B |
| December 31, 2018 | 8.061B |
| September 30, 2018 | 8.785B |
| June 30, 2018 | 3.743B |
| March 31, 2018 | 9.474B |
| December 31, 2017 | 9.789B |
| Date | Value |
|---|---|
| September 30, 2017 | 9.554B |
| June 30, 2017 | 7.205B |
| March 31, 2017 | 6.248B |
| December 31, 2016 | 6.423B |
| September 30, 2016 | 7.95B |
| June 30, 2016 | 8.002B |
| March 31, 2016 | 8.60B |
| December 31, 2015 | 8.407B |
| September 30, 2015 | 9.249B |
| June 30, 2015 | 8.279B |
| March 31, 2015 | 7.924B |
| December 31, 2014 | 8.374B |
| September 30, 2014 | 7.728B |
| June 30, 2014 | 10.25B |
| March 31, 2014 | 9.10B |
| December 31, 2013 | 9.895B |
| September 30, 2013 | 9.596B |
| June 30, 2013 | 8.754B |
| March 31, 2013 | 7.479B |
| December 31, 2012 | 7.976B |
| September 30, 2012 | 4.586B |
| June 30, 2012 | 74.54M |
| March 31, 2012 | 42.99M |
| December 31, 2011 | 653.00M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
5.416B
Minimum
Jun 2019
41.14B
Maximum
Mar 2020
12.65B
Average
9.777B
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Amgen Inc | 10.94B |
| Immunogen Inc (DELISTED) | 605.54M |
| Johnson & Johnson | 22.93B |
| Eli Lilly and Co | 2.928B |
| Merck & Co Inc | 7.093B |